Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-11

Clinical Trial Update: The Possible Protective Role of Ketotifen Against Oxaliplatin Induced Peripheral Neuropathy [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is investigating whether ketotifen can protect against oxaliplatin-induced peripheral neuropathy; the study is currently recruiting at …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketotifen (Ketotifen)

Snippet

Sponsor: Tanta University | Conditions: Neuropathy;Peripheral | Phase 3 | Status: RECRUITING